Metsera

Public

New York City, New YorkBiotechhttps://www.metsera.com

Last Round

M&A

Nov 13, 2025

Est. Valuation

$7B

Total Funding Raised

$7.82B

Company Overview

Metsera is a biopharmaceutical company focused on developing innovative therapies for obesity and metabolic diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

GLP-1/GIP/Glucagon tri-agonistnext-generation incretin therapyobesity drug developmentmetabolic disease drug developmentoral incretin therapyinjectable obesity therapyclinical-stage drug pipeline for obesityAmylin and Calcitonin analoguepeptide and small molecule drug discovery

Metsera Comps

Public and private peers based on sector, stage, and business model.

Metsera comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Metsera Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Nov 13, 2025
IPO Announced	Feb 3, 2025
Series B	Nov 12, 2024
Series A	Apr 18, 2024

View all Funding Rounds

Metsera Investors

Notable investors and investment history

Metsera investors
Investor	Rounds
Newpath Partners	Series B, Series A
Evercore ISI	IPO
Janus Henderson Group	Series B
SoftBank Investment Advisers	Series B, Series A
SymBiosis Capital Management	Series B
RA Capital Management	Series B
GV	Series B, Series A

View all Investors

Metsera Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Metsera Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersNew York City, New York

Employee Range108

Year Founded2022

Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.